Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
about
4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.Quantification of methamphetamine, amphetamine and enantiomers by semi-micro column HPLC with fluorescence detection; applications on abusers' single hair analyses.Chiral resolution of four major flavanones in post-administrative urine of Chinese herbal medicines by HPLC on macroporous silica gel coated with cellulose tris(3,5-dimethylphenylcarbamate).Studies of metabolite-protein interactions: a reviewIntra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice.Metabolic profiling of praziquantel enantiomers.Chiral drugs: an overview.Protein binding of propranolol and verapamil enantiomers in maternal and foetal serumPharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients.Stereoselective disposition of flurbiprofen in normal volunteersStereoselective pharmacokinetics and pharmacodynamics of anti-asthma agents.Modulation of the host response in periodontal therapy.Direct resolution and quantitative analysis of flurbiprofen enantiomers using microcrystalline cellulose triacetate plates: applications to the enantiomeric purity control and optical isomer determination in widely consumed drugs.The therapeutic promise of single enantiomers: introduction.Bidirectional enantioselective effects of the GABAB receptor agonist baclofen in two mouse models of excessive ethanol consumption.Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs.Mirror images: the analysis of pharmaceutical enantiomers.Bioequivalence of racemic drugs.Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.The stereochemical course of 4-hydroxy-2-nonenal metabolism by glutathione S-transferasesStereoselectivity in drug metabolism.Potential therapeutic uses of mecamylamine and its stereoisomers.Stereoselective pharmacokinetics of ifosfamide in male and female rats.Clinical pharmacokinetics of fexofenadine enantiomers.Chiral high performance liquid chromatography of drug molecules.Thin-layer chromatography enantioseparations on chiral stationary phases: a review.Ketorolac tromethamine - routes and clinical implications.Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.The Effect of Geometrical Isomerism of 3,5-Dicaffeoylquinic Acid on Its Binding Affinity to HIV-Integrase Enzyme: A Molecular Docking Study.Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man.Stereochemical aspects of pharmacotherapy.Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.Hematologic disposition of hydroxychloroquine enantiomers.Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.Chirality and drugs used to treat psychiatric disorders.Stereoselectivity of the folate transporter in rabbit small intestine: studies with amethopterin enantiomers.Stereoselective binding and degradation of sulbenicillin in the presence of human serum albumin.Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity.Pharmacokinetics of the active antifungal enantiomer, SCH 42427 (RR), and evaluation of its chiral inversion in animals following its oral administration and the oral administration of its racemate genaconazole (RR/SS).
P2860
Q24535682-69A33B2A-11F8-4551-A548-D4A45F3353BBQ30912130-3529746C-2A85-4428-8E67-88BA11822AEBQ32053317-C161C717-680B-4316-9401-B39EE987C014Q33657421-7D2D0046-9BB2-436D-80F8-58C25FA09FA5Q34052435-F7EED6B2-5886-483C-8056-16B216EAC949Q34208792-8B7F59B7-2F54-4BD0-8F51-6B3971B6FDB5Q34344756-812D1489-D0C5-4652-ACFF-69D46F26417CQ34346873-BD9A1D27-F077-45F4-8F07-4B8C56228E75Q34358409-8FD34079-8B44-4EA2-AA0E-87F5F123046AQ34402943-9DA38EE7-A8DD-4DFC-A18B-A8BE0F7DBCA3Q34579642-E1CD7C6A-3B2A-478F-9E0D-D83797DC0D1EQ34624681-6B216C90-A425-43B2-B87A-9F30543BCB10Q34801592-8D9E4089-FE17-42A0-885E-840EDEE26778Q34982621-22687CB3-61AB-42F9-ADCA-43A0AA655D6BQ35039864-68B857A4-2066-4DBB-B505-AE30500CC8A7Q35054997-DF668ED6-D249-48B1-A682-53C818B127ECQ35536298-25EF48F9-104C-49D5-9380-C61D78348D1AQ35536304-8175B365-4F66-4C89-B8EC-4C67A9A5204CQ35756163-1E0F28D6-32EE-470A-A86A-04D6D82D478FQ35827117-08595819-65EB-4EB7-B600-913A8AC201DAQ36711101-0C68D30A-52C9-4D96-AD51-DFA3FEB4BEE6Q36788391-941D4030-AABE-40C3-8B6B-C9691F8EB509Q36949979-20A62E52-E2D9-4F67-A19D-7CE7DB2E8759Q37361514-D8794E90-FC69-4CBF-9016-1E8821F546B9Q37641373-152D73FD-E8B4-4FBC-88F7-79287C5A0B39Q38035204-491661A0-4018-42AD-A64A-9D645AB86FDFQ38060593-07F08A05-B202-4F95-B4DF-A51CD06D71FCQ38205005-0DA3E54E-67DD-429C-B1D0-1F73168A1E6AQ40316973-9BABA0F8-4E67-4BED-BEE7-06C973ECE394Q40481860-E68B8ACE-9254-4AB4-BE14-C7CF4D98E91FQ40515294-BCB05592-E919-442D-89DD-E5E31F9FCC1FQ40950958-86731B10-E5F8-4256-AB43-E4200FBA8D8FQ41906194-9F74DEA3-4F63-41B2-A680-373F87A5DB55Q41934460-BC8367DF-B36C-45BE-9C9B-82262945B03DQ42064858-495E315A-1DC6-4126-8E37-94A629E133FAQ42875648-C73AD177-47FC-43CC-BB18-2B8FCE70E06FQ43554681-8BBF7DC6-9E4E-4092-B441-7FC662034D1BQ43585308-56FF7B23-2F52-4304-B455-703EB619BDECQ43857564-1FB74A55-42DF-4F25-B3A3-D72A1B4BF6BEQ43976736-A252D62B-5C1C-479C-A34F-403946494E7A
P2860
Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
@en
type
label
Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
@en
prefLabel
Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
@en
P2093
P356
P1476
Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
@en
P2093
P304
P356
10.1002/JPS.2600780902
P407
P577
1989-09-01T00:00:00Z